These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 14709191

  • 1. Postmenopausal hormone therapy and migraine headache.
    Misakian AL, Langer RD, Bensenor IM, Cook NR, Manson JE, Buring JE, Rexrode KM.
    J Womens Health (Larchmt); 2003 Dec; 12(10):1027-36. PubMed ID: 14709191
    [Abstract] [Full Text] [Related]

  • 2. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F, Manson JE, Stampfer MJ.
    J Womens Health (Larchmt); 2006 Dec; 15(1):35-44. PubMed ID: 16417416
    [Abstract] [Full Text] [Related]

  • 3. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
    Parazzini F, Progetto Menopausa Italia Study Group.
    Menopause; 2008 Dec; 15(1):164-70. PubMed ID: 17581495
    [Abstract] [Full Text] [Related]

  • 4. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA.
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [Abstract] [Full Text] [Related]

  • 5. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y, Scheidt-Nave C, Schaffrath Rosario A, Ellert U, Dören M, Knopf H.
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [Abstract] [Full Text] [Related]

  • 6. Past oral contraceptive and hormone therapy use and endogenous hormone concentrations in postmenopausal women.
    Chan MF, Dowsett M, Folkerd E, Wareham N, Luben R, Welch A, Bingham S, Khaw KT.
    Menopause; 2008 Aug; 15(2):332-9. PubMed ID: 17667152
    [Abstract] [Full Text] [Related]

  • 7. Prevalence and correlates of panic attacks in postmenopausal women: results from an ancillary study to the Women's Health Initiative.
    Smoller JW, Pollack MH, Wassertheil-Smoller S, Barton B, Hendrix SL, Jackson RD, Dicken T, Oberman A, Sheps DS, Women's Health Initiative Investigators.
    Arch Intern Med; 2003 Sep 22; 163(17):2041-50. PubMed ID: 14504117
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Estrogen therapy and risk of breast cancer in postmenopausal women: a case-control study and results of a multivariate analysis.
    Lumachi F, Frigo AC, Basso U, Tombolan V, Ermani M.
    Menopause; 2010 Sep 22; 17(3):524-8. PubMed ID: 20130492
    [Abstract] [Full Text] [Related]

  • 11. Self-reported urogenital symptoms in postmenopausal women: Women's Health Initiative.
    Pastore LM, Carter RA, Hulka BS, Wells E.
    Maturitas; 2004 Dec 10; 49(4):292-303. PubMed ID: 15531125
    [Abstract] [Full Text] [Related]

  • 12. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E, Zyriax BC, Eidenmüller B, Boeing H.
    Maturitas; 2007 Jul 20; 57(3):239-46. PubMed ID: 17292571
    [Abstract] [Full Text] [Related]

  • 13. Postmenopausal hormone use in women with acute coronary syndromes.
    Parsons E, Newby LK, Bhapkar MV, Alexander KP, White HD, Shah SH, Bushnell CD, Califf RM, Symphony and 2nd Symphony Investigators.
    J Womens Health (Larchmt); 2004 Oct 20; 13(8):863-71. PubMed ID: 15671702
    [Abstract] [Full Text] [Related]

  • 14. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
    Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, Aggerwal A, David Curb J, Hendrix SL, Allan Hubbell F, Khandekar J, Lane DS, Lasser N, Lopez AM, Potter J, Ritenbaugh C.
    Maturitas; 2006 Sep 20; 55(2):103-15. PubMed ID: 16815651
    [Abstract] [Full Text] [Related]

  • 15. Colorectal cancer in middle-aged women in relation to hormonal status: a report from the Women's Health in the Lund Area (WHILA) study.
    Nazeri K, Khatibi A, Nyberg P, Agardh CD, Lidfeldt J, Samsioe G.
    Gynecol Endocrinol; 2006 Aug 20; 22(8):416-22. PubMed ID: 17012102
    [Abstract] [Full Text] [Related]

  • 16. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
    Blümel JE, Chedraui P, Baron G, Belzares E, Bencosme A, Calle A, Danckers L, Espinoza MT, Flores D, Gomez G, Hernandez-Bueno JA, Izaguirre H, Leon-Leon P, Lima S, Mezones-Holguin E, Monterrosa A, Mostajo D, Navarro D, Ojeda E, Onatra W, Royer M, Soto E, Tserotas K, Vallejo S, Collaborative Group for Research of the Climacteric in Latin America (REDLINC).
    Menopause; 2011 Jul 20; 18(7):778-85. PubMed ID: 21407137
    [Abstract] [Full Text] [Related]

  • 17. Epidemiological and clinical aspects of migraine in users of combined oral contraceptives.
    Machado RB, Pereira AP, Coelho GP, Neri L, Martins L, Luminoso D.
    Contraception; 2010 Mar 20; 81(3):202-8. PubMed ID: 20159175
    [Abstract] [Full Text] [Related]

  • 18. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA, Blake JM, Crosignani PG.
    Hum Reprod Update; 2005 Mar 20; 11(6):545-60. PubMed ID: 16150813
    [Abstract] [Full Text] [Related]

  • 19. Women's issues of migraine in tertiary care.
    Kelman L.
    Headache; 2004 Jan 20; 44(1):2-7. PubMed ID: 14979877
    [Abstract] [Full Text] [Related]

  • 20. Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?
    Salpeter S.
    Climacteric; 2005 Dec 20; 8(4):307-10. PubMed ID: 16390764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.